Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT03900221 RESPONSE — French Registry for Monitoring Pregnancies for Multiple Scle… |
RESPONSE — French Registry for Mo… | SEP | À vérifier | RECRUITING | En attente / non publié | Hospices Civils de Lyon | France, Martinique · Cabinet médical Dr C. CORNUT-CHA… | 2019-08-12 → 2036-08-12 | Ouvrir |
| NCT04202055 BIOMOG — Immunologic Biomarker Profile of Cerebrospinal Fluid |
BIOMOG — Immunologic Biomarker Pr… | SEP | À vérifier | COMPLETED | En attente / non publié | Centre Hospitalier Universitaire … | France · CHU de Nîmes, Nîmes, France | 2018-01-02 → 2019-08-31 | Ouvrir |
| NCT02433028 SMSC — Swiss Multiple Sclerosis Cohort-Study |
SMSC — Swiss Multiple Sclerosis C… | SEP | À vérifier | RECRUITING | En attente / non publié | University Hospital, Basel, Switz… | Switzerland · Cantonal Hospital Aarau, Aarau, Switzer… | 2012-06 → 2042-01 | Ouvrir |
| NCT06572059 MotorImagery — Upper Extremity Motor Imagery Functional Skills and Qual… |
MotorImagery — Upper Extremity Mo… | SEP | À vérifier | COMPLETED | En attente / non publié | Kahramanmaras Sutcu Imam Universi… | Turkey (Türkiye) · Hatice Adiguzel, Kahramanmaraş, Tu… | 2023-07-07 → 2023-10-30 | Ouvrir |
| NCT01918501 Testing Mitochondria Activity and Blood Lipid Content of Multiple Scler… |
Blood testing | SEP | Non applicable | UNKNOWN | En attente / non publié | Ziv Hospital | Israel · Ziv Medical Center, Safed, Israel | 2013-08 → 2015-07 | Ouvrir |
| NCT06315972 OligoTreat — Combining Clemastine and Aerobic Exercise to Treat Cogniti… |
clemastine (8 mg/day) | SEP | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | LMU Klinikum | Non communiqué | 2024-04 → 2028-04 | Ouvrir |
| NCT04042363 ONSTIM — Effect of Transorbital Electrical STIMulation of Optic Nerve o… |
Transorbital electrical stimulati… | SEP | Non applicable | UNKNOWN | En attente / non publié | Centre Hospitalier National d'Oph… | France · Centre Hospitalier National d'Ophtalmologie … | 2019-07-10 → 2022-07 | Ouvrir |
| NCT07526493 Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of… |
Universal CD19 CAR-γδT Cell Injec… | SEP | Phase 1 | RECRUITING | En attente / non publié | Tongji Hospital | China · Tongji Hospital, Tongji Medical College, Huaz… | 2026-04-01 → 2028-12-31 | Ouvrir |
| NCT02040298 ReBUILD — Assessment of Clemastine Fumarate as a Remyelinating Agent in… |
Clemastine | SEP | Phase 2 | COMPLETED | En attente / non publié | University of California, San Fra… | United States · UCSF Multiple Sclerosis Center, San F… | 2014-01 → 2016-04 | Ouvrir |
| NCT06683612 PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS an… |
PIPE-791 | SEP | Phase 1 | COMPLETED | En attente / non publié | Contineum Therapeutics | United Kingdom · Hammersmith Medicines Research, Lond… | 2024-12-09 → 2025-06-12 | Ouvrir |
| NCT06711354 B-cell Depletion in Offspring to Women With MS Under Immunomodulatory T… |
Anti-CD20 Monoclonal Antibody | SEP | À vérifier | UNKNOWN | En attente / non publié | Region Stockholm | Non communiqué | 2025-06 → 2025-12 | Ouvrir |
| NCT04971005 COAST — Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoiet… |
Autologous Hematopoietic Stem Cel… | SEP | Phase 2 | TERMINATED | En attente / non publié | Universitätsklinikum Hamburg-Eppe… | Germany · Universitätsklinikum Hamburg-Eppendorf, Ham… | 2021-08-27 → 2022-02-04 | Ouvrir |
| NCT02807285 Expanded Access Program for Ocrelizumab in Participants With Primary Pr… |
Ocrelizumab | SEP | À vérifier | NO_LONGER_AVAILABLE | En attente / non publié | Hoffmann-La Roche | United States · Abington Neurological Associates, Wil… | Non communiqué | Ouvrir |
| NCT05123703 Operetta 2 — A Study to Evaluate Safety and Efficacy of Ocrelizumab in … |
Ocrelizumab | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Australia, Austria, Belgium… | 2022-05-19 → 2029-09-17 | Ouvrir |
| NCT04458688 Investigating the Effect of Ocrelizumab in African Americans and Caucas… |
Investigating the Effect of Ocrel… | SEP | À vérifier | RECRUITING | En attente / non publié | Wayne State University | United States · Wayne State University, Detroit, Unit… | 2021-11-20 → 2030-12 | Ouvrir |
| NCT06526000 Study to Assess Changes in Immunoglobulins in Patients With Relapsing M… |
Study to Assess Changes in Immuno… | SEP | À vérifier | COMPLETED | En attente / non publié | Novartis | United States · Novartis Pharmaceuticals, East Hanove… | 2022-10-11 → 2024-02-28 | Ouvrir |
| NCT02708927 EMOSOCIAL-MS — Emotional Processing, Family Life, Friendship and Social… |
EMOSOCIAL-MS — Emotional Processi… | SEP | Non applicable | COMPLETED | En attente / non publié | University Hospital, Bordeaux | France · CHU de Bordeaux, Bordeaux, France | CHU de D… | 2016-03-03 → 2019-01-28 | Ouvrir |
| NCT05787795 DREAM — Identifying and Characterizing Preclinical MS |
DREAM — Identifying and Character… | SEP | À vérifier | RECRUITING | En attente / non publié | Yale University | United States · Yale University, North Haven, United … | 2022-06-21 → 2033-06-30 | Ouvrir |
| NCT07789171 Synbiotic-MS — Synbiotic Supplementation as a Part of Dietary Modificat… |
Synbiotic-MS — Synbiotic Suppleme… | SEP | Non applicable | COMPLETED | En attente / non publié | Hacettepe University | Turkey (Türkiye) · Hacettepe University, Ankara, Turk… | 2020-03-01 → 2023-11-29 | Ouvrir |
| NCT07788859 Reliability and Validity of Three DT-TUG Protocols in MS |
Reliability and Validity of Three… | SEP | À vérifier | RECRUITING | En attente / non publié | Afyonkarahisar Health Sciences Un… | Turkey (Türkiye) · SANKO University, Gaziantep, Turke… | 2026-03-16 → 2026-09-14 | Ouvrir |
| NCT05999604 WINDOCRE — Impact of Annual Versus Biannual Infusions of Ocrelizumab in… |
Ocrelizumab Injection [Ocrevus] | SEP | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Fondation Ophtalmologique Adolphe… | France · CH Gonesse, Gonesse, France | CHI Poissy-Sai… | 2023-11-09 → 2028-05 | Ouvrir |
| NCT06433752 ENABLE — A Study Evaluating the Real World Experience of Participants T… |
ENABLE — A Study Evaluating the R… | SEP | À vérifier | RECRUITING | En attente / non publié | TG Therapeutics, Inc. | United States, Puerto Rico · TG Therapeutics Investig… | 2024-07-22 → 2032-04-01 | Ouvrir |
| NCT04626245 Mindfulness & Mechanisms Study |
Mindfulness & Mechanisms Study | Hypertension | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Lifespan | United States · Women's Medicine Collaborative, Provi… | 2022-06-13 → 2027-06-30 | Ouvrir |
| NCT07785895 Huawei-SunU1 — Real-World Validation of Huawei Wearable Technologies fo… |
Huawei-SunU1 — Real-World Validat… | Hypertension | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Sunway University | Malaysia · Faculty of Medical and Life Sciences, Sunw… | 2026-10-01 → 2028-12-31 | Ouvrir |
| NCT07783802 CLARITY-CRP — A Study of Clazakizumab (LY5724886) in Adults With Elevat… |
Clazakizumab | Hypertension | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Eli Lilly and Company | United States, Argentina, Japan, Puerto Rico · Accell… | 2026-09 → 2027-10 | Ouvrir |